Abstract
MANAGEMENT OF HER 2 POSITIVE BREAST CANCER
Liban Mahdi Mohamed*, Nguomo Louba, Belhaouz Ismail, Benhessou Moustapha and Kerroumi Mohamed
ABSTRACT
Breast cancer is a heterogeneous disease. However, immunohistochemistry techniques have made it possible to distinguish 3 types of breast cancer: those which express hormonal receptors (the most common: 68% of cases), others which express the HER2 growth factor receptor (21% of cases) and the triple negative molecular type (the least common 11%). HER 2+ breast cancer is defined by the expression of HER2 receptors. Currently, knowing one's status with respect to the HER2 receptor allows one to know whether one can benefit from targeted anti-HER2 treatment.
[Full Text Article] [Download Certificate]WJPLS CITATION
All | Since 2019 | |
Citation | 422 | 322 |
h-index | 9 | 7 |
i10-index | 4 | 2 |
INDEXING
NEWS & UPDATION
BEST PAPER AWARDS
World Journal of Pharmaceutical and life sciences Will give best paper award in every issue in the from of money along with certificate to promote research .
Best Article of current issue
Download Article : Click here